MIR 19® – world first specific antiviral drug for COVID-19 treatment: development and preclinical studies
Authors:
- M.R. KhaitovMKM.R. Khaitov
- I.P. ShilovskiyISI.P. Shilovskiy
- K.V. KozhikhovaKKK.V. Kozhikhova
- I.A. KofiadiIKI.A. Kofiadi
- G.O. GudimaGGG.O. Gudima
- L.I. VishniakovaLVL.I. Vishniakova
- A.A. NikolskiiANA.A. Nikolskii
- V.I. KovchinaVKV.I. Kovchina
- E.D. TimotievichETE.D. Timotievich
- K.V. YumashevKYK.V. Yumashev
- V.V. SmirnovVSV.V. Smirnov
- A.V. MaerleAMA.V. Maerle
Open Access
- 1 January 2023
- journal article
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 44 (3)